Young adults with type 2 diabetes (T2D) and low income face a starkly higher risk of death compared with their higher-income counterparts, according to a large nationwide cohort study from South Korea.1 Young man frustrated with finances | Image credit: […]
Young Adults With Low Incomes Have Higher Diabetes Mortality Risk Read More »
Noninvasive liver fibrosis scores, commonly used to assess liver disease severity, are now being linked to a higher prevalence of heart failure in the general US population.1 A recent study published in the Journal of the American Heart Association analyzed
Liver Fibrosis Scores May Hint at Heart Failure Risk Read More »
β-blockers, long trusted for survivors of heart attacks, may not be as essential or safe for all patients as once believed. A recent study from Sweden suggests these drugs could increase depression risk in heart attack survivors who retained normal
β-Blockers May Raise Depression Risk for Heart Attack Survivors Without Heart Failure Read More »
Abortion rights were on the ballot in the 2024 election, and 4 states that lent their votes to President-elect Donald J. Trump also passed ballot measures protecting abortion under their state’s Constitution: Arizona, Missouri, Montana, and Nevada. State-level protection was
5 Things About State Votes to Protect Abortion Rights Read More »
High levels of omega-3 and omega-6 fatty acids—often called “healthy fats”—may help protect against various types of cancer, according to new research published in the International Journal of Cancer.1 Drawing from data on over 250,000 participants in the UK Biobank
High Omega-3, Omega-6 Levels May Lower Cancer Risk Read More »
Lawsuits claim that an agreement between GoodRx and major PBMs drives down pharmacy reimbursements while increasing fees | Image credit: Zerbor – stock.adobe.com GoodRx and multiple pharmacy benefit managers (PBMs) have been hit by class action lawsuits alleging the companies
GoodRx, PBMs Hit by Price Fixing Lawsuits Read More »
The latest report from Trilliant Health, discussed by Sanjula Jain, PhD, chief research officer at Trilliant Health, revealed troubling trends within the US health care system. Sanjula Jain, PhD | Image credit: Trilliant Health In an interview with The American
US Health Care Spending “Defies Laws of Economics” Read More »
The gene therapy landscape for Duchenne muscular dystrophy (DMD) has encountered major hurdles in 2024, as 2 high-profile trials—Sarepta’s EMBARK and Pfizer’s CIFFREO—failed to meet their primary endpoints. Both trials aimed to treat DMD by delivering genetic material to help
Sarepta Joins Pfizer in DMD Gene Therapy Trial Failures Read More »
New research presented at the AMCP Nexus 2024 fall conference revealed the significant toll that caregiving for individuals with Duchenne muscular dystrophy (DMD) can take on work productivity and daily life. DMD, a rare genetic disorder characterized by progressive muscle
Studies Highlight Heavy Burden on Caregivers of Patients With DMD Read More »
A clinical trial investigating oral zinc supplementation in boys with Duchenne muscular dystrophy (DMD) found the treatment did not significantly improve key health measures.1 Published in Nutrients, the study focused on zinc’s role in muscle health and cellular function and aimed
Zinc Supplements Fall Short for Boys With Duchenne Muscular Dystrophy Read More »
